Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elke Hartmann

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|December 7, 2007
ESTP comments on the draft updated OECD test guideline 407Elke Hartmann, Volker Strauss, Rolf Eiben, et al.
Journal of Toxicologic Pathology|January 25, 2012
Pathology in Continuous Infusion Studies in Rodents and Non-Rodents and ITO (Infusion Technology Organisation)-Recommended Protocol for Tissue Sampling and Terminology for Procedure-Related LesionsKlaus Weber, Vasanthi Mowat, Elke Hartmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 22, 2021
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney diseaseAgnès Bénardeau, Antje Kahnert, Tibor Schomber, et al.
International Journal of Molecular Sciences|September 9, 2023
The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 RatsJan R Kraehling, Agnes Benardeau, Tibor Schomber, et al.
Journal of Medicinal Chemistry|November 14, 2024
Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus ResolutionChantal Fürstner, Jens Ackerstaff, Heinrich Meier, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Experimental and Toxicologic Pathology : Official Journal of the Gesellschaft Fur Toxikologische Pathologie|December 7, 2007
ESTP comments on the draft updated OECD test guideline 407Elke Hartmann, Volker Strauss, Rolf Eiben, et al.
Journal of Toxicologic Pathology|January 25, 2012
Pathology in Continuous Infusion Studies in Rodents and Non-Rodents and ITO (Infusion Technology Organisation)-Recommended Protocol for Tissue Sampling and Terminology for Procedure-Related LesionsKlaus Weber, Vasanthi Mowat, Elke Hartmann, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|September 22, 2021
Runcaciguat, a novel soluble guanylate cyclase activator, shows renoprotection in hypertensive, diabetic, and metabolic preclinical models of chronic kidney diseaseAgnès Bénardeau, Antje Kahnert, Tibor Schomber, et al.
International Journal of Molecular Sciences|September 9, 2023
The sGC Activator Runcaciguat Has Kidney Protective Effects and Prevents a Decline of Kidney Function in ZSF1 RatsJan R Kraehling, Agnes Benardeau, Tibor Schomber, et al.
Journal of Medicinal Chemistry|November 14, 2024
Discovery and Preclinical Characterization of Fulacimstat (BAY 1142524), a Potent and Selective Chymase Inhibitor As a New Profibrinolytic Approach for Safe Thrombus ResolutionChantal Fürstner, Jens Ackerstaff, Heinrich Meier, et al.
Pageof 3